PHXM Annual Accounts Payable
$1.68 M
-$1.14 M-40.46%
31 December 2022
Summary:
As of February 4, 2025, PHXM annual accounts payable is $1.68 million, with the most recent change of -$1.14 million (-40.46%) on December 31, 2022. During the last 3 years, it has fallen by -$4.01 million (-70.53%).PHXM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Quarterly Accounts Payable
N/A
30 September 2023
Summary:
PHXM quarterly accounts payable is not available.PHXM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.5% | - |
| 3 y3 years | -70.5% | - |
| 5 y5 years | -71.9% | - |
PHXM Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -89.1% |
PHAXIAM Therapeutics SA Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $4.71 M(+181.3%) |
| Dec 2022 | $1.68 M(-40.5%) | $1.68 M(-35.7%) |
| June 2022 | - | $2.60 M(-7.4%) |
| Dec 2021 | $2.81 M(-51.4%) | $2.81 M(-29.5%) |
| June 2021 | - | $3.99 M(-31.1%) |
| Dec 2020 | $5.79 M(+1.8%) | $5.79 M(+41.1%) |
| June 2020 | - | $4.10 M(-27.8%) |
| Dec 2019 | - | $5.68 M(-59.0%) |
| Dec 2019 | $5.68 M(-62.9%) | - |
| Sept 2019 | - | $13.85 M(+6.0%) |
| June 2019 | - | $13.07 M(-14.8%) |
| Dec 2018 | - | $15.33 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $15.33 M(+157.3%) | - |
| June 2018 | - | $14.30 M(+145.0%) |
| Dec 2017 | $5.96 M(+16.6%) | $5.84 M(-17.2%) |
| June 2017 | - | $7.05 M(+38.0%) |
| Dec 2016 | $5.11 M(+27.2%) | $5.11 M(+1.6%) |
| June 2016 | - | $5.03 M(+25.2%) |
| Dec 2015 | $4.01 M(+58.3%) | $4.01 M(-6.8%) |
| June 2015 | - | $4.31 M(+69.9%) |
| Dec 2014 | $2.54 M(+29.2%) | $2.54 M(+29.0%) |
| June 2014 | - | $1.97 M(+0.1%) |
| Dec 2013 | $1.96 M(+16.5%) | $1.96 M(-21.8%) |
| June 2013 | - | $2.51 M(+49.0%) |
| Dec 2012 | $1.69 M | $1.69 M |
FAQ
- What is PHAXIAM Therapeutics SA annual accounts payable?
- What is the all time high annual accounts payable for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual accounts payable?
The current annual accounts payable of PHXM is $1.68 M
What is the all time high annual accounts payable for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual accounts payable is $15.33 M
What is PHAXIAM Therapeutics SA annual accounts payable year-on-year change?
Over the past year, PHXM annual accounts payable has changed by -$1.14 M (-40.46%)
What is the all time high quarterly accounts payable for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly accounts payable is $15.33 M